Status:
COMPLETED
Study of MK-0476 in Adult Patients With Acute Asthma (0476-334)
Lead Sponsor:
Organon and Co
Conditions:
Asthma
Eligibility:
All Genders
15-75 years
Phase:
PHASE3
Brief Summary
The study estimates the efficacy and safety of MK0476 and aminophylline intravenous administration in adult participants with acute asthma.
Eligibility Criteria
Inclusion
- Adult participants with acute asthma attacks
Exclusion
- Participant has any known or suspected, acute or chronic cause for their pulmonary symptoms other than asthma (e.g., COPD, chronic heart failure, etc.).
- Participant has a smoking habit (15 cigarettes per day) within a month prior to screening period, and/or has a smoking history (20 cigarettes per day) of more than 15 years.
- Participant has a disease of the cardiovascular, hepatic, renal, hematologic systems, or other severe disease.
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2007
Estimated Enrollment :
91 Patients enrolled
Trial Details
Trial ID
NCT00442338
Start Date
March 1 2007
End Date
August 1 2007
Last Update
February 2 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.